M. Kate Curtis1, Brianna J Stubbs1, Vicky Ball1, Lowri E Cochlin2, Mark A Cole3, Jack J Miller1,4, David P O'Neill1, Kieran Clarke1, Peter A Robbins1, and Damian J Tyler1,5
1Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom, 2PulseTeq Ltd, Surrey, United Kingdom, 3Queen's Medical Centre, University of Nottingham Medical School, Nottingham, United Kingdom, 4Physics, University of Oxford, Oxford, United Kingdom, 5Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
Synopsis
Previous techniques used to determine the hierarchy
of skeletal muscle metabolic fuel selection have been unable to directly
describe the changes in cellular metabolic flux during exercise. The aim of this project was to develop
a technique that allows the simultaneous assessment of metabolism and function in
exercising skeletal muscle in real-time, in an intact mouse, using
hyperpolarized [1-13C] pyruvate MRS. Our results demonstrate that
the technique is sensitive enough to distinguish differences in metabolic flux
between the resting and exercising states shown by a significant increase in 13C
label incorporation into bicarbonate during exercise.Introduction
The hierarchy of metabolic fuel selection in
resting skeletal muscle, where fat oxidation inhibits carbohydrate utilisation
1,
is thought not to operate during exercise
2,3. However, previous work
underpinning our understanding of skeletal muscle substrate utilisation during
exercise has relied predominantly on the measurement of by-products of fat and
carbohydrate metabolism in a variety of cellular and animal models. These
include tracer experiments following electrical stimulation of muscle
homogenates
4 or isolated perfused whole-muscle preparations
5,
and measurement of arterio-venous differences across electrically stimulated whole-limb
preparations
6. These methods are unable to describe directly the
changes in cellular metabolic flux during exercise. The aim of this project was
to develop a technique that allows metabolism and functional measurements of
exercising skeletal muscle in real-time, in an intact animal. A method of
in vivo murine gastrocnemius muscle
stimulation was established for measurement of force production and fatigue
resistance. We combined this with a protocol measuring muscle metabolism using
hyperpolarized [1-
13C] pyruvate magnetic resonance spectroscopy
(MRS), to follow conversion of pyruvate to downstream metabolites including
lactate, alanine and bicarbonate
7. This technique allows for the
simultaneous measurement of metabolic flux and assessment of skeletal muscle force
production and fatigue resistance during exercise in intact animals.
Methods
Hyperpolarized 13C MRS protocol: [1-13C] pyruvate
was hyperpolarized using a prototype hyperpolarizer and dissolved as previously
described8,9. An aliquot of 0.2 mL of 80 mM hyperpolarized [1-13C]
pyruvate solution was injected over 10 seconds via a tail vein cannula into an
anaesthetised mouse positioned in a 7 T preclinical Varian/Agilent MR scanner.
Spectra were acquired for one minute post-injection, using a 10 µs 15º hard excitation pulse (TR=1
s, 8kHz bandwidth). Signal was localised to the gastrocnemius muscle using a 13C
RF surface coil. The first 30 spectra after the appearance of the pyruvate peak
were summed and analysed using the AMARES algorithm in the jMRUI software package10
and results are shown as the ratio of the returned amplitude of the metabolite
of interest to that of pyruvate.
In vivo
gastrocnemius muscle stimulation: Three month old
C57BL/6 male mice underwent an in vivo
gastrocnemius muscle stimulation protocol in conjunction with two
hyperpolarized scans, one before the stimulation protocol with the muscle in a
resting state and one during the stimulation protocol (n=3, mean body mass 29 g).
An anaesthetised mouse was placed in a bespoke Perspex cradle designed and
manufactured for this protocol. A cannula was inserted into the tail vein. The sciatic
nerve was isolated surgically and electrodes were placed distal to the tibial
nerve branch. The knee and ankle joints were immobilised, the calcaneal tendon
was attached to a force transducer via a suture thread, before a 13C
RF saddle coil was placed over the muscle. Gradient echo 1H localiser
images were then used to obtain the cross-sectional area (CSA) of the
gastrocnemius muscle. Hyperpolarized [1-13C] pyruvate was injected
in to the tail vein and spectra acquired every second over one minute from the
muscle at rest. After 30 minutes a stimulation protocol11 consisting
of a train of eight pulses of 100 μs at 30 Hz followed by a rest period of 1.25
seconds was repeated over a 10 minute period using a PowerLab system and
induced force production measured over this time. When the gastrocnemius muscle
was exercising at a steady state, around four minutes in to the exercise
period, hyperpolarized [1-13C] pyruvate was again injected in to the
tail vein and spectra acquired as before.
Results
13C spectra were
acquired successfully at rest and during exercise. Figure 1 shows the force
produced over the ten minute stimulation period normalised to the CSA of the
hindlimb. Figure 2 shows an increase in flux through pyruvate dehydrogenase
demonstrated by a significant (p =0.031) increase in [1-
13C] label incorporation
from pyruvate through to bicarbonate during exercise compared to muscle at
rest.
Discussion
A method of
in
vivo gastrocnemius muscle stimulation was successfully established. The
protocol mimicked the cyclical contraction pattern the gastrocnemius muscle
would undergo during a running motion. Combining this stimulation method with
hyperpolarized [1-
13C] pyruvate MRS facilitated the simultaneous
assessment of skeletal muscle metabolism and function. Our results demonstrate
that the technique is sensitive enough to distinguish the differences in
metabolic flux between the resting and exercising state. This technique may
provide new insights into muscle fuel utilisation during exercise, which can be
complicated by disease or nutrition.
Acknowledgements
This work was supported by Vifor Pharma and The Royal Commission for
1851.References
1 Randle et al., Lancet.
(1963); 7285.1: 785-9. 2 Van Loon et al., J.
Physiol. (2001); 536.1:
295–304. 3 Romijn et al., J. Appl.?Physiol. (1995); 79(6): 1939-1945. 4 Lynge et al., J. Physiol. (2001), 537.2:
597–605.
5
Aslesen
et al., J Appl Physiol. (2001) 91: 1237–1244. 6 Silveira et al.,Cell Physiol Biochem. (2007); 20: 213-226. 7 Dodd et al., J. Cardiovasc Magnetic Resonance.
(2013); 15(19).
8 Golman et al., PNAS. (2006); 103: (30):
11270-5. 9 Schroeder et al.,
PNAS. (2008); 105(33): 12051-6. 10 Naressi et al., Comput Biol Med. (2001); 31:269-286. 11 Cole et al., Neruromuscl Disord. (2002);
12(3): 247-57.